[1] ROEST P A, ROBERTS R G, SUGINO S. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. 1993(10). doi:10.1093/hmg/2.10.1719 [2] BODER E, SEDGWICK R P. Ataxia-telangiectasia, a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report of 7 children, an autopsy, and a case history, 1957 [3] RASIO D, NEGRINI M, Croce C M. Genomic organization of the ATM locus involved in ataxia-telangiectasia, 1995 [4] Vorechovsky I, LUO L, LINDBLOM A. ATM mutations in cancer families, 1996 [5] Uziel T, SAVITSKY K, PLATZER M. Genomic organization of the ATM gene. 1996. doi:10.1006/geno.1996.0201 [6] GILAD S, KHOSRAVI R, SHKEDY D. Predominance of null mutations in ataxia-telangiectasia. 1996(5). doi:10.1093/hmg/5.4.433 [7] Wooster R, FORD D, MANGION J. Absence of linkage to the ataxia-telangiectasia locus in familial breast cancer. 1993. doi:10.1007/BF00216153 [8] Cortessis V, INGLES S, MILLIKAN R. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene in 64 families with premenopausal bilateral breast cancer, 1993 [9] Athma P, RAPPAPORT R, SWIFT M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. 1996. doi:10.1016/S0165-4608(96)00328-7 [10] Easton D. Cancer risks in A-T heterozygotes. 1994. doi:10.1080/09553009414552011 [11] Broeks A, URBANUS J H, FLOORE A N. ATM-he~terozygous germline mutations contribute to breast cancer-susceptibility, 2000 [12] LAAKE K, VU P, ANDERSEN T I. Screening breast cancer patients for Norwegian ATM mutations, 2000 [13] DRUMEA K C, LEVINE E, BERNSTEIN J. ATM he-terozygosity and breast cancer:screening of 37 breast cancer patients for ATM mutations using a non-isotopic Rnase cleavage-based assay. 2000. doi:10.1023/A:1006463730337 |